microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart

Genes and Development

Volumn 22, Issue 23, 2008, Pages 3242-3254

  Liu, Ning ^a   Bezprozvannaya, Svetlana ^a   Williams, Andrew H ^a   Qi, Xiaoxia ^a   Richardson, James A ^a,b   Bassel Duby, Rhonda ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cyclin D2; Heart development; microRNA; Myocyte enhancer factor 2; Serum response factor

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 133A; MICRORNA 133A 1; MICRORNA 133A 2; UNCLASSIFIED DRUG;

ARTICLE; CARDIOMYOPATHY; ELECTRIC POTENTIAL; GENE EXPRESSION; HEART DEVELOPMENT; HEART FAILURE; HEART VENTRICLE SEPTUM DEFECT; MOUSE; MUSCLE DEVELOPMENT; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE;

ANIMALS; BASE SEQUENCE; CELL PROLIFERATION; CYCLINS; GENE EXPRESSION REGULATION; GENES, CDC; HEART DEFECTS, CONGENITAL; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICRORNAS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MUTATION; MYOCYTES, CARDIAC;

MUS;

EID: 57749121689     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1738708     Document Type: Article

References (49)

1. Baek, D., Villen, J., Shin, C., Camargo, F.D., Gygi, S.P., and Bartel, D.P. 2008. The impact of microRNAs on protein output. Nature 455: 64-71.
2. Black, F.M., Packer, S.E., Parker, T.G., Michael, L.H., Roberts, R., Schwartz, R.J., and Schneider, M.D. 1991. The vascular smooth muscle α-actin gene is reactivated during cardiac hypertrophy provoked by load. J. Clin. Invest. 88: 1581-1588.
3. Boutz, P.L., Chawla, G., Stoilov, P., and Black, D.L. 2007a. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes & Dev. 21: 71-84.
4. Boutz, P.L., Stoilov, P., Li, Q., Lin, C.H., Chawla, G., Ostrow, K., Shiue, L., Ares Jr., M., and Black, D.L. 2007b. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes & Dev. 21: 1636-1652.
5. Care, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.L., Segnalini, P., Gu, Y., Dalton, N.D., et al. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13: 613-618.
6. Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L., and Wang, D.Z. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38: 228-233.
7. Hoffman, J.I. and Kaplan, S. 2002. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39: 1890-1900.
8. Jin, Y., Blue, E.K., Dixon, S., Shao, Z., and Gallagher, P.J. 2002. A death-associated protein kinase (DAPK)-interacting protein, DIP-1, is an E3 ubiquitin ligase that promotes tumor necrosis factor-induced apoptosis and regulates the cellular levels of DAPK. J. Biol. Chem. 277: 46980-46986.
9. Kim, Y., Phan, D., van Rooij, E., Wang, D.Z., McAnally, J., Qi, X., Richardson, J.A., Hill, J.A., Bassel-Duby, R., and Olson, E.N. 2008. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J. Clin. Invest. 118: 124-132.
10. Kumar, A., Crawford, K., Close, L., Madison, M., Lorenz, J., Doetschman, T., Pawlowski, S., Duffy, J., Neumann, J., Robbins, J., et al. 1997. Rescue of cardiac α-actin-deficient mice by enteric smooth muscle γ-actin. Proc. Natl. Acad. Sci. 94: 4406-4411.
11. Leung, A.K. and Sharp, P.A. 2007. microRNAs: A safeguard against turmoil? Cell 130: 581-585.
12. Li, L., Miano, J.M., Cserjesi, P., and Olson, E.N. 1996. SM22 α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78: 188-195.
13. Liu, N., Williams, A.H., Kim, Y., McAnally, J., Bezprozvannaya, S., Sutherland, L.B., Richardson, J.A., Bassel-Duby, R., and Olson, E.N. 2007. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc. Natl. Acad. Sci. 104: 20844-20849.
14. Luo, X., Lin, H., Pan, Z., Xiao, J., Zhang, Y., Lu, Y., Yang, B., and Wang, Z. 2008. Downregulation of MIRNA-1/MIRNA-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J. Biol. Chem. 283: 20045-20052.
15. McCarthy, J.J. 2008. MicroRNA-206: The skeletal muscle-specific myomiR. Biochim. Biophys. Acta. 1779: 682-691.
16. McHugh, K.M. 1995. Molecular analysis of smooth muscle development in the mouse. Dev. Dyn. 204: 278-290.
17. Miano, J.M., Long, X., and Fujiwara, K. 2007. Serum response factor: Master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 292: C70-C81. doi: 10.1152/ajpcell.00386.2006.
18. Montgomery, R.L., Davis, C.A., Potthoff, M.J., Haberland, M., Fielitz, J., Qi, X., Hill, J.A., Richardson, J.A., and Olson, E.N. 2007. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes & Dev. 21: 1790-1802.
19. Nelson, T.J., Balza Jr., R., Xiao, Q., and Misra, R.P. 2005. SRF-dependent gene expression in isolated cardiomyocytes: Regulation of genes involved in cardiac hypertrophy. J. Mol. Cell. Cardiol. 39: 479-489.
20. Ng, W.A., Grupp, I.L., Subramaniam, A., and Robbins, J. 1991. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ. Res. 68: 1742-1750.
21. Niu, Z., Li, A., Zhang, S.X., and Schwartz, R.J. 2007. Serum response factor micromanaging cardiogenesis. Curr. Opin. Cell Biol. 19: 618-627.
22. Olson, E.N. 2006. Gene regulatory networks in the evolution and development of the heart. Science 313: 1922-1927.
23. Owens, G.K., Kumar, M.S., and Wamhoff, B.R. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84: 767-801.
24. Pasumarthi, K.B., Nakajima, H., Nakajima, H.O., Soonpaa, M.H., and Field, L.J. 2005. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ. Res. 96: 110-118.
25. Pipes, G.C., Creemers, E.E., and Olson, E.N. 2006. The myocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis. Genes & Dev. 20: 1545-1556.
26. Potthoff, M.J. and Olson, E.N. 2007. MEF2: A central regulator of diverse developmental programs. Development 134: 4131-4140.
27. Rodriguez, C.I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R., Stewart, A.F., and Dymecki, S.M. 2000. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25: 139-140.
28. Ruzicka, D.L. and Schwartz, R.J. 1988. Sequential activation of α-actin genes during avian cardiogenesis: Vascular smooth muscle α-actin gene transcripts mark the onset of cardiomyocyte differentiation. J. Cell Biol. 107: 2575-2586.
29. Schaub, M.C., Hefti, M.A., Harder, B.A., and Eppenberger, H.M. 1997. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J. Mol. Med. 75: 901-920.
30. Selbach, M., Schwanhausser, B., Thierfelder, N., Fang, Z., Khanin, R., and Rajewsky, N. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
31. Shin, C.H., Liu, Z.P., Passier, R., Zhang, C.L., Wang, D.Z., Harris, T.M., Yamagishi, H., Richardson, J.A., Childs, G., and Olson, E.N. 2002. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110: 725-735.
32. Sprenkle, A.B., Murray, S.F., and Glembotski, C.C. 1995. Involvement of multiple cis elements in basal- and α-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element. Circ. Res. 77: 1060-1069.
33. Strzelecka-Golaszewska, H. and Sobieszek, A. 1981. Activation of smooth muscle myosin by smooth and skeletal muscle actins. FEBS Lett. 134: 197-202.
34. Thai, T.H., Calado, D.P., Casola, S., Ansel, K.M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J.L., et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
35. Valencia-Sanchez, M.A., Liu, J., Hannon, G.J., and Parker, R. 2006. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes & Dev. 20: 515-524.
36. van Bilsen, M. and Chien, K.R. 1993. Growth and hypertrophy of the heart: Towards an understanding of cardiac specific and inducible gene expression. Cardiovasc. Res. 27: 1140-1149.
37. van Rooij, E. and Olson, E.N. 2007. MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J. Clin. Invest. 117: 2369-2376.
38. van Rooij, E., Sutherland, L.B., Qi, X., Richardson, J.A., Hill, J., and Olson, E.N. 2007. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579.
39. van Rooij, E., Liu, N., and Olson, E.N. 2008. MicroRNAs flex their muscles. Trends Genet. 24: 159-166.
40. Ventura, A., Young, A.G., Winslow, M.M., Lintault, L., Meissner, A., Erkeland, S.J., Newman, J., Bronson, R.T., Crowley, D., Stone, J.R., et al. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886.
41. Wang, Z., Wang, D.Z., Hockemeyer, D., McAnally, J., Nordheim, A., and Olson, E.N. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428: 185-189.
42. Wang, S., Aurora, A.B., Johnson, B.A., Qi, X., McAnally, J., Hill, J.A., Richardson, J.A., Bassel-Duby, R., and Olson, E.N. 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15: 261-271.
43. Xiao, C., Calado, D.P., Galler, G., Thai, T.H., Patterson, H.C., Wang, J., Rajewsky, N., Bender, T.P., and Rajewsky, K. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
44. + channel expression contributing to QT prolongation in diabetic hearts. J. Biol. Chem. 282: 12363-12367.
45. Xin, M., Davis, C.A., Molkentin, J.D., Lien, C.L., Duncan, S.A., Richardson, J.A., and Olson, E.N. 2006. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc. Natl. Acad. Sci. 103: 11189-11194.
46. Xu, C., Lu, Y., Pan, Z., Chu, W., Luo, X., Lin, H., Xiao, J., Shan, H., Wang, Z., and Yang, B. 2007. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J. Cell Sci. 120: 3045-3052.
47. Zhang, X., Azhar, G., Chai, J., Sheridan, P., Nagano, K., Brown, T., Yang, J., Khrapko, K., Borras, A.M., Lawitts, J., et al. 2001. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am. J. Physiol. Heart Circ. Physiol. 280: H1782-H1792.
48. Zhao, Y., Samal, E., and Srivastava, D. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-220.
49. Zhao, Y., Ransom, J.F., Li, A., Vedantham, V., von Drehle, M., Muth, A.N., Tsuchihashi, T., McManus, M.T., Schwartz, R.J., and Srivastava, D. 2007. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129: 303-317.